Monthly Measure Archives - Page 9 of 12

What is Small Cell Lung Cancer?

Bethany Johnson (GO2 for Lung Cancer)2023-09-20T12:46:30-05:00April 8th, 2021|Hot Topics, Monthly Measure, Newsletter Articles, Science and Research, Small Cell Lung Cancer|

By Daniel A. Saez, M.Sc., Treatment and Trials Navigator, GO2 for Lung Cancer Patients diagnosed with Small Cell Lung Cancer (SCLC) have new hope because of recent advances in early detection and treatment. To amplify this positive message, we [...]

2

Five Communities Spring Into Action for GO2 for Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2021-04-08T11:25:45-05:00April 8th, 2021|Community Engagement, Monthly Measure, Newsletter Articles|

Thank you to everyone who joined us for our first-ever Step into Spring Virtual Step Challenge! You blew our goal out of the water, logging over 10 Million Steps for lung cancer and raising over $91,000 for our programs [...]

0

Advocacy for Lung Cancer is Personal

Bethany Johnson (GO2 for Lung Cancer)2021-04-21T13:19:31-05:00April 7th, 2021|Advocacy in Action, Hot Topics, Monthly Measure, Newsletter Articles|

What an impact our community can make! On March 23-25, 2021, we brought together survivors, patients, caregivers, family & friends, healthcare professionals to listen, learn, share, and tell their members of Congress about the needs of the lung [...]

0

3 Keys to a More Integrated Approach to Lung Health

Bethany Johnson (GO2 for Lung Cancer)2021-03-11T08:52:23-06:00March 11th, 2021|Hot Topics, Monthly Measure|

McLeod Health was looking for a better way to detect and track lung health across its one million plus patient population. The health system includes 7 hospitals across South Carolina, along with a growing network of primary care [...]

0

Cracking the Code on Lung Cancer in Younger Adults

Bethany Johnson (GO2 for Lung Cancer)2021-03-15T09:54:22-05:00March 11th, 2021|Hot Topics, Monthly Measure, Science and Research|

Stephen Huff & family, Stage IV lung cancer Why are younger adults getting lung cancer? There is a growing cohort of younger adults who are being diagnosed with lung cancer. Alarmingly, the research points to [...]

0

Jog for Jill—and Honor the Woman Who Inspired a Generation

Bethany Johnson (GO2 for Lung Cancer)2021-03-11T08:46:20-06:00March 11th, 2021|Community Engagement, Hot Topics, Monthly Measure|

One person can make a difference. If you have any doubt, look no further than the legacy of Jill Costello, a college student at the University of California at Berkeley who was diagnosed with Stage 4 lung cancer [...]

0

Increasing Diversity in Clinical Trials

Bethany Johnson (GO2 for Lung Cancer)2021-03-15T09:42:15-05:00March 8th, 2021|Hot Topics, Monthly Measure, Science and Research|

It may seem like clinical trials are suddenly top of mind here at GO2 for Lung Cancer, with new articles about inclusive research and demystifying them with a brand-new FAQ. But clinical trials and the diversity of the patients within [...]

0

The Race to 60K Before 60

Bethany Johnson (GO2 for Lung Cancer)2021-02-11T11:09:31-06:00February 11th, 2021|Community Engagement, Hot Topics, Monthly Measure|

Terri Ann DiJulio set an audacious goal last winter of raising $60,000 for GO2 for Lung Cancer before she turns 60 in January, 2021. The birthday fundraising campaign, entitled 60 for Sixty was off to a strong start... then [...]

2

2020 World Conference on Lung Cancer (in 2021)

Bethany Johnson (GO2 for Lung Cancer)2021-04-13T09:14:18-05:00February 11th, 2021|Monthly Measure, Science and Research|

By Jennifer C. King, PhD, Chief Scientific Officer, GO2 for Lung Cancer New advances in lung cancer research were presented earlier this year at the 2020 World Conference on Lung Cancer (WCLC). Due to the COVID-19 pandemic, this conference [...]

0

Patients First

Bethany Johnson (GO2 for Lung Cancer)2021-01-08T11:44:10-06:00January 8th, 2021|Monthly Measure, Stories of Hope|

Australian Lisa Briggs is proof that living on a different continent is no impediment to connecting with GO2 for Lung Cancer. In 2014, after months of misdiagnosis, she learned she had stage IV lung cancer, ALK-positive. The 32-year-old healthcare [...]

1